Epizyme Inc (EPZM.OQ)
EPZM.OQ on NASDAQ Stock Exchange Global Select Market
15.30USD
23 Apr 2018
15.30USD
23 Apr 2018
Change (% chg)
$-0.55 (-3.47%)
$-0.55 (-3.47%)
Prev Close
$15.85
$15.85
Open
$15.95
$15.95
Day's High
$16.05
$16.05
Day's Low
$15.23
$15.23
Volume
139,532
139,532
Avg. Vol
123,684
123,684
52-wk High
$21.35
$21.35
52-wk Low
$9.35
$9.35
Select another date:
Mon, Apr 23 2018
BRIEF-Epizyme Provides Update Regarding Tazemetostat Clinical Program
* EPIZYME PROVIDES UPDATE REGARDING TAZEMETOSTAT CLINICAL PROGRAM
BRIEF-Epizyme Inc Files For Potential Mixed Shelf, Size Not Disclosed
* EPIZYME INC FILES FOR POTENTIAL MIXED SHELF; SIZE NOT DISCLOSED - SEC FILING Source text: (https://bit.ly/2q8HM38) Further company coverage:
BRIEF-Epizyme Q4 Loss Per Share $0.52
* EPIZYME REPORTS FOURTH QUARTER AND FULL YEAR 2017 OPERATING RESULTS AND 2018 MILESTONES
Select another date:
- Biotech Analysis Central Pharma News: Orexigen's Last Resort, Epizyme's Partial Clinical Hold, Eli Lilly And Incyte's Mixed Advisory Panel Vote
- Epizyme (EPZM) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow
- Epizyme's (EPZM) CEO Robert Bazemore on Q4 2017 Results - Earnings Call Transcript
- Biotech Forum Daily Digest For January 24th
- Your Daily Pharma Scoop: AbbVie Highlights Pipeline, Novavax Surges, Lipocine Flops At Ad Com
- Biotech Forum Daily Digest For January 10th